The test may make it easier to identify whether people with memory and thinking problems have Alzheimer’s or not.

The FDA cleared marketing for the first in vitro diagnostic device that tests blood to aid in diagnosing Alzheimer disease.

The US Food and Drug Administration has given marketing clearance to a blood test to help diagnose Alzheimer’s disease, ...

The very first blood test for Alzheimer's disease detection has been green-lit by the US Food and Drug Administration (FDA), ...

The first in vitro diagnostic device that uses blood samples to detect Alzheimer disease has been granted marketing clearance by the US Food and Drug Administration.

The blood test is used to detect abnormal protein deposits in the brain that are associated with Alzheimer's. The test is for people 55 and older who are already showing signs of the disease, ...

The FDA has granted 510(k) marketing clearance to the first in vitro blood-based biomarker diagnostic device for Alzheimer’s ...

Analysts at BMO Capital Markets said in a weekend note that a non-invasive blood test could help boost uptake of Alzheimer’s ...

The Lumipulse G pTau217/Beta-Amyloid 1-42 Plasma Ratio is for the early detection of amyloid plaques associated with Alzheimer’s disease in symptomatic adults 55 years and older.

Fujirebio Diagnostics Inc.’s Alzheimer’s disease assay received the U.S. FDA’s first clearance for a blood test for the ...

There's a new way to screen for early detection of Alzheimer's disease. On Friday, the Food and Drug Administration (FDA) ...

The FDA has approved the first blood test to help detect Alzheimer’s disease. Developed by Fujirebio Diagnostics, the ...